ESC/ EACTS guidelines for the management of valvular heart disease, Eur Heart J, vol.38, pp.2739-91, 2017. ,
5-year outcomes of transcatheter aortic valve replacement or surgical aortic valve replacement for high surgical risk patients with aortic stenosis (PART-NER 1): a randomised controlled trial, Lancet, vol.385, pp.2477-84, 2015. ,
Transcatheter aortic valve replacement versus surgical valve replacement in intermediate-risk patients: a propensity score analysis, Lancet, vol.387, pp.2218-2243, 2016. ,
Transcatheter aortic valve implantation in the United Kingdom: temporal trends, predictors of outcome, and 6-year follow-up: a report from the UK Transcatheter Aortic Valve Implantation (TAVI) Registry, Circulation, vol.131, pp.1181-90, 2007. ,
Temporal trends in transcatheter aortic valve replacement in France: FRANCE 2 to FRANCE TAVI, J Am Coll Cardiol, vol.70, pp.42-55, 2017. ,
URL : https://hal.archives-ouvertes.fr/hal-01744757
Access options for transcatheter aortic valve replacement in patients with unfavorable aortoiliofemoral anatomy, Curr Cardiol Rep, vol.18, p.110, 2016. ,
, , 2017.
AHA/ACC guideline for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines, J Am Coll Cardiol, vol.70, pp.252-89, 2014. ,
Transcarotid transcatheter aortic valve implantation: multicentre experience in France, Eur J Cardiothorac Surg, vol.53, pp.157-61, 2018. ,
Transubclavian approach: a competitive access for transcatheter aortic valve implantation as compared to transfemoral, Catheter Cardiovasc Interv, vol.92, pp.935-979, 2018. ,
Transcutaneous aortic valve implantation using the left carotid access: feasibility and early clinical outcomes, Ann Thorac Surg, vol.93, pp.1489-94, 2012. ,
Aortic valve implantation with the CoreValve ReValving System via left carotid artery access: first case report, J Thorac Cardiovasc Surg, vol.140, pp.928-937, 2010. ,
Propensity-matched comparisons of clinical outcomes after transapical or transfemoral transcatheter aortic valve replacement: a placement of aortic transcatheter valves (PARTNER)-I trial substudy, Circulation, vol.131, pp.1989-2000, 2015. ,
Propensity-matched comparison of clinical outcomes after transaortic versus transfemoral aortic valve replacement, EuroIntervention, vol.14, pp.750-757, 2018. ,
Updated standardized endpoint definitions for transcatheter aortic valve implantation: the Valve Academic Research Consortium-2 consensus document, Eur Heart J, vol.33, pp.2403-2421, 2012. ,
VARC endpoint definition compliance rates in contemporary transcatheter aortic valve implantation studies, EuroIntervention, vol.12, pp.375-80, 2016. ,
The making of STROBE, Epidemiology, vol.18, pp.797-806, 2007. ,
,
, Transcatheter aortic-valve replacement with a self-expanding valve in low-risk patients, N Engl J Med, vol.380, pp.1706-1721, 2019.
Transcarotid compared with other alternative access routes for transcatheter aortic valve replacement, Circ Cardiovasc Interv, vol.11, p.6388, 2018. ,
Conscious sedation versus general anesthesia in transcatheter aortic valve replacement: the German Aortic Valve Registry, J Am Coll Cardiol Intv, vol.11, pp.567-78, 2018. ,
Comparison of safety and periprocedural complications of transfemoral aortic valve replacement in local anesthesia in minimalist versus complete heart team, EuroIntervention, vol.14, pp.1819-1844, 2019. ,
Vascular complications after transcatheter aortic valve replacement: insights from the PARTNER (Placement of AoRTic TraNscathetER Valve) trial, J Am Coll Cardiol, vol.60, pp.1043-52, 2012. ,
Cerebral embolism following transcatheter aortic valve implantation: comparison of transfemoral and transapical approaches, J Am Coll Cardiol, vol.57, pp.18-28, 2011. ,
Silent cerebral injury after transcatheter aortic valve implantation and the preventive role of embolic protection devices: a systematic review and metaanalysis, Int J Cardiol, vol.221, pp.97-106, 2016. ,
Predictors of cerebrovascular events at mid-term after transcatheter aortic valve implantationresults from EVERY-TAVI registry, Int J Cardiol, vol.244, pp.106-117, 2017. ,
A prospective randomized evaluation of the Tri-Guard TM HDH embolic DEFLECTion device during transcatheter aortic valve implantation: results from the DEFLECT III trial, Eur Heart J, vol.36, pp.2070-2078, 2015. ,